Nymox Pharmaceutical
NYMX
#10548
Rank
A$26.5 M
Marketcap
Country
A$0.29
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.37 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$9.48 Million, an increase over its 2021 earnings that were of -A$18.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.37 Million-64.45%
2022 -A$9.48 Million-47.71%
2021 -A$18.13 Million6.61%
2020 -A$17.01 Million-10.91%
2019 -A$19.09 Million24.24%
2018 -A$15.36 Million-20.03%
2017 -A$19.21 Million2.71%
2016 -A$18.7 Million-63.86%
2015 -A$51.75 Million674.44%
2014 -A$6.69 Million-6.11%
2013 -A$7.12 Million-35.66%
2012 -A$11.07 Million-20.76%
2011 -A$13.96 Million38.33%
2010 -A$10.1 Million35.59%
2009 -A$7.45 Million11.8%
2008 -A$6.66 Million-12.94%
2007 -A$7.65 Million8.85%
2006 -A$7.03 Million36.5%
2005 -A$5.15 Million-4.4%
2004 -A$5.39 Million-14.58%
2003 -A$6.31 Million
2001 -A$4.63 Million-20.54%
2000 -A$5.82 Million21.72%
1999 -A$4.79 Million-25.56%
1998 -A$6.43 Million101.3%
1997 -A$3.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.72 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.38 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.81 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.19 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.99 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA